MedPath

An observational study to evaluate outcomes of Percutaneous Coronary Intervention of patients with ST elevation MI over 1 year.

Not yet recruiting
Conditions
Acute myocardial infarction, unspecified,
Registration Number
CTRI/2019/12/022379
Lead Sponsor
Dr Chirag Sheth
Brief Summary

THIS OBSERVATIONAL STUDY IS BEING CONDUCTED TO EVALUATE THE EARLY AND LATE OUTCOMES OF PERCUTANEOUS CORONARY ANGIOPLASTY AFTER ST ELEVATION MYOCARDIAL INFARCTION AT A TERTIARY CARE CENTRE IN INDIA. THE LONG TERM DATA OF PRIMARY PCI, EARLY PHARMACOINVASIVE APPROACH AND RESCUE PCI IS SPARSE IN INDIA. SO THIS OBSERVATIONAL STUDY IS IMPORTANT TO EVALUATE THE OUTCOME OF SUCH PATIENTS IN INDIAN SCENARIO.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
500
Inclusion Criteria

All patients undergoing Percutaneous coronary Intervention with ST elevation Myocardial Infraction present within 7 days of index event.

Exclusion Criteria
  • 1.Age less than or equal to 18 years 2.Patient undergoing Coronary Artery Bypass Surgery.
  • 3.Patients with ST Elevation Myocardial Infarction not undergoing Pecutaneous interaction either due to co-morbid condition or anatomy not suitable for PCI.
  • 4.Pregnancy.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Composite of all cause death, myocardial infarction, ischemia driven revascularization, hospitalization for heart failure.Timepoints are as described below: | 1] 7th day of discharge | 2] At 1 month | 3] At 3 months | 4] At 6 months | 5] At 12 months
Secondary Outcome Measures
NameTimeMethod
1.Cardiac death2.Hospitalization for acute coronary syndrome

Trial Locations

Locations (1)

Rhythm Heart Istitute

🇮🇳

Vadodara, GUJARAT, India

Rhythm Heart Istitute
🇮🇳Vadodara, GUJARAT, India
Dr Chirag Sheth
Principal investigator
02652541006
drcvs_73@yahoo.co.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.